Viewing Study NCT00393458


Ignite Creation Date: 2025-12-25 @ 12:12 AM
Ignite Modification Date: 2025-12-25 @ 10:14 PM
Study NCT ID: NCT00393458
Status: COMPLETED
Last Update Posted: 2011-08-18
First Post: 2006-10-25
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: Efficacy, Safety, and Tolerability of Once Daily Indacaterol in Chronic Obstructive Pulmonary Disease (COPD) Using Formoterol Twice Daily as Active Control
Sponsor: Novartis
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2006-10
Start Date Type: None
Primary Completion Date: 2008-07
Primary Completion Date Type: ACTUAL
Completion Date: 2008-07
Completion Date Type: ACTUAL
First Submit Date: 2006-10-25
First Submit QC Date: None
Study First Post Date: 2006-10-27
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2011-07-22
Results First Submit QC Date: None
Results First Post Date: 2011-08-18
Results First Post Date Type: ESTIMATED
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2011-07-22
Last Update Post Date: 2011-08-18
Last Update Post Date Type: ESTIMATED